The acute phase protein serum amyloid A (SAA) as an inflammatory marker in equine influenza virus infection.
The acute phase protein serum amyloid A (SAA) has proven potentially useful as an inflammatory marker in the horse, but the knowledge of SAA responses in viral diseases is limited. The aim of this study was to evaluate SAA as a marker for acute equine influenza A2 (H3N8) virus infection. This is a highly contagious, serious condition that inflicts suffering on affected horses and predisposes them to secondary bacterial infections and impaired performance. Seventy horses, suffering from equine influenza, as verified by clinical signs and seroconversion, were sampled in the acute (the first 48 h) and convalescent (days 11-22) stages of the disease, and SAA concentrations were determined. Clinical signs and rectal temperature were recorded. Secondary infections, that could have influenced SAA concentrations, were clinically suspected in 4 horses. SAA concentrations were higher in the acute stage than in the convalescent stage, and there was a statistically positive relationship between acute stage SAA concentrations and clinical signs and between acute stage SAA concentrations and maximal rectal temperature. Horses sampled early in the acute stage had lower SAA concentrations than those sampled later, indicating increasing concentrations during the first 48 h. There was a statistically positive relationship between convalescent SAA concentrations and degree of clinical signs during the disease process. The results of this investigation indicate that equine SAA responds to equine influenza infection by increasing in concentration during the first 48 h of clinical signs and returning to baseline within 11-22 days in uncomplicated cases.
Department of Clinical Chemistry, Faculty of Veterinary Medicine, Swedish University of Agricultural Sciences, Uppsala, Sweden. cecilia.hulten@klke.slu.se
C
C
Hultén
B
B
Sandgren
E
E
Skiöldebrand
B
B
Klingeborn
G
G
Marhaug
M
M
Forsberg
D000209:Acute-Phase Proteins / Q000096:biosynthesis / Q000276:immunology*; D000367:Age Factors; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis / Q000097:blood; D015415:Biomarkers / Q000097:blood; D001831:Body Temperature; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect / Q000662:veterinary; D006385:Hemagglutination Inhibition Tests / Q000662:veterinary; D006734:Horse Diseases / Q000276:immunology* / Q000821:virology; D006736:Horses; D007124:Immunoenzyme Techniques / Q000662:veterinary; D009980:Influenza A virus / Q000276:immunology*; D016014:Linear Models; D008297:Male; D009297:Nasal Mucosa / Q000821:virology; D009976:Orthomyxoviridae Infections / Q000097:blood / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D011897:Random Allocation; D012016:Reference Values; D000685:Serum Amyloid A Protein / Q000096:biosynthesis / Q000276:immunology*; D012737:Sex Factors
D000209:Acute-Phase Proteins; D000914:Antibodies, Viral; D015415:Biomarkers; D000685:Serum Amyloid A Protein